NCT05412914

Brief Summary

This study to compare the impacts of remimazolam or propofol on the left ventricular global longitudinal strain (LV-GLS) during anesthesia induction for non-cardiac surgery. LV-GLS is analyzed by using speckle tracking technique of transthoracic echocardiography.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Jan 2023

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 31, 2021

Completed
9 months until next milestone

First Posted

Study publicly available on registry

June 9, 2022

Completed
8 months until next milestone

Study Start

First participant enrolled

January 26, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2024

Completed
Last Updated

October 10, 2023

Status Verified

October 1, 2023

Enrollment Period

11 months

First QC Date

August 31, 2021

Last Update Submit

October 5, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • the averaged longitudinal strain of the left ventricle (%)

    inter-group comparisons of the lowest values of the longitudinal strains of the left ventricle in the transthoracic echocardiography after administering remimazolam- or propofol-administration for anesthesia induction

    2.5 minutes

Secondary Outcomes (4)

  • the longitudinal strain of the left ventricle in apical long-axis view (%)

    2.5 minutes

  • the longitudinal strain of the left ventricle in apical 2 chamber view (%)

    2.5 minutes

  • the longitudinal strain of the left ventricle in apical 4 chamber view (%)

    2.5 minutes

  • the election fraction of the left ventricle

    2.5 minutes

Study Arms (2)

Remimazolam

EXPERIMENTAL

remimazolam infusion

Drug: Remimazolam infusion

Propofol

ACTIVE COMPARATOR

propofol infusion

Drug: Propofol infusion

Interventions

Remimazolam infusion for anesthesia induction

Also known as: Byfavo
Remimazolam

Propofol infusion for anesthesia induction

Also known as: Fresofol
Propofol

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • left ventricular ejection fraction\> 50%
  • no left ventricular regional wall motion abnormality

You may not qualify if:

  • atrial fibrillation
  • unfavorable airway
  • hypotension requiring inotropic support

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Konkuk University Medical Center

Seoul, 05030, South Korea

RECRUITING

MeSH Terms

Interventions

Propofol

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic Chemicals

Study Officials

  • Tae-Yop Kim, MD, PhD

    Konkuk University Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tae-Yop Kim, MD, PhD

CONTACT

Soi Lee

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Department of Anesthesiology

Study Record Dates

First Submitted

August 31, 2021

First Posted

June 9, 2022

Study Start

January 26, 2023

Primary Completion

January 1, 2024

Study Completion

January 1, 2024

Last Updated

October 10, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations